A detailed history of Russell Investments Group, Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,150,602 shares of ABBV stock, worth $195 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
1,150,602
Previous 1,067,907 7.74%
Holding current value
$195 Million
Previous $183 Million 24.05%
% of portfolio
0.34%
Previous 0.3%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $13.5 Million - $16.5 Million
82,695 Added 7.74%
1,150,602 $227 Million
Q2 2024

Aug 08, 2024

SELL
$154.79 - $180.76 $1.41 Million - $1.64 Million
-9,084 Reduced 0.84%
1,067,907 $183 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $3.28 Million - $3.74 Million
20,543 Added 1.94%
1,076,991 $196 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $12 Million - $13.5 Million
87,370 Added 9.02%
1,056,448 $164 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $12.7 Million - $14.7 Million
95,308 Added 10.91%
969,078 $144 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $1.87 Million - $2.33 Million
14,146 Added 1.65%
873,770 $118 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $2.07 Million - $2.38 Million
14,308 Added 1.69%
859,624 $137 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $10.2 Million - $12.2 Million
-73,809 Reduced 8.03%
845,316 $137 Million
Q3 2022

Nov 04, 2022

BUY
$134.21 - $153.93 $6.81 Million - $7.81 Million
50,747 Added 5.84%
919,125 $124 Million
Q2 2022

Jul 29, 2022

BUY
$137.62 - $174.96 $2.18 Million - $2.77 Million
15,837 Added 1.86%
868,378 $133 Million
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $24.5 Million - $30.4 Million
-185,399 Reduced 17.86%
852,541 $138 Million
Q4 2021

Jan 21, 2022

SELL
$107.43 - $135.93 $6.32 Million - $7.99 Million
-58,811 Reduced 5.36%
1,037,940 $141 Million
Q3 2021

Nov 08, 2021

SELL
$106.4 - $120.78 $9.29 Million - $10.6 Million
-87,359 Reduced 7.38%
1,096,751 $118 Million
Q2 2021

Aug 04, 2021

SELL
$105.21 - $117.21 $23.9 Million - $26.6 Million
-227,160 Reduced 16.1%
1,184,110 $133 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $13.4 Million - $14.7 Million
-130,656 Reduced 8.47%
1,411,270 $153 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $24.3 Million - $32.8 Million
-301,816 Reduced 16.37%
1,541,926 $165 Million
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $8.88 Million - $10.4 Million
-103,355 Reduced 5.31%
1,843,742 $161 Million
Q2 2020

Aug 05, 2020

SELL
$73.37 - $98.18 $45.5 Million - $60.8 Million
-619,469 Reduced 24.14%
1,947,097 $191 Million
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $8.23 Million - $12.5 Million
127,544 Added 5.23%
2,566,566 $195 Million
Q4 2019

Jan 29, 2020

BUY
$72.13 - $90.25 $10.7 Million - $13.4 Million
148,690 Added 6.49%
2,439,022 $216 Million
Q3 2019

Nov 01, 2019

BUY
$62.98 - $75.72 $57.5 Million - $69.1 Million
913,015 Added 66.29%
2,290,332 $173 Million
Q2 2019

Aug 09, 2019

BUY
$65.7 - $83.98 $45.4 Million - $58.1 Million
691,365 Added 100.79%
1,377,317 $99.2 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $12 Million - $14.1 Million
155,134 Added 29.23%
685,952 $55.1 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $26.3 Million - $32.4 Million
-337,425 Reduced 38.86%
530,818 $48.8 Million
Q3 2018

Oct 26, 2018

BUY
$88.91 - $98.84 $15.4 Million - $17.1 Million
173,222 Added 24.92%
868,243 $82.1 Million
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $12.4 Million - $14.7 Million
-138,022 Reduced 16.57%
695,021 $64.4 Million
Q1 2018

May 11, 2018

BUY
$92.01 - $123.21 $27.5 Million - $36.8 Million
299,025 Added 56.0%
833,043 $78.5 Million
Q4 2017

Feb 06, 2018

SELL
$89.56 - $98.21 $2.74 Million - $3 Million
-30,556 Reduced 5.41%
534,018 $52.2 Million
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $39.4 Million - $50.4 Million
564,574
564,574 $50.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.